New York Firm Raises $48 Million To Develop New Cancer Immunotherapies

Quentis Therapeutics says it has raised $48 million from venture capitalists to develop drugs that unleash the immune system against cancer.

Original Article: New York Firm Raises $48 Million To Develop New Cancer Immunotherapies

More From BioPortfolio on "New York Firm Raises $48 Million To Develop New Cancer Immunotherapies"

• Related Companies
• Related Events
• Related Clinical Trials
• Related PubMed Entries
• Related Medications